3D lung surgery planning with a dye to find tumors
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new way to plan and guide lung cancer surgery using a special dye that shows the tumor area during the operation. It may help surgeons remove the cancer more accurately while targeting only a small section of lung for certain early-stage patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your lung tumor is smaller than 3 cm
- You have early-stage non-small cell lung cancer (stage 1)
- Scans show the tumor is limited to one specific lung segment and you’re a candidate for segment removal
- You are not allergic to indocyanine green (ICG), sodium iodide, or iodine
- Your pregnancy/breastfeeding status and birth control fit the trial safety rules
- Your pre-surgery lung tests are strong enough (FEV1 and DLCO are above 30% of predicted)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new method using 3D virtual reality and a special dye (indocyanine green) to help surgeons see and remove only the affected part of the lung, preserving healthy tissue. It is for people with early-stage lung cancer that is small and located in one section of the lung.
This early-stage trial tests a robotic lung surgery that uses a special dye with near-infrared light to help the surgeon remove only the tumor area. If you have a small, early lung cancer, this approach may help improve accuracy while limiting how much lung is removed.
This trial tests whether 3D models from a CT scan without dye can help guide minimally invasive lung surgery. If you have a small early-stage lung cancer and are eligible for keyhole surgery, this study might be for you.
This trial tests a single dose of a special dye (LS301-IT) that helps surgeons see lung cancer cells more clearly during surgery. It aims to make lung cancer removal more precise and complete.
This trial compares two methods to help surgeons find the right section of the lung to remove during surgery. One method uses a special green dye, and the other uses air to inflate and deflate the lung. The goal is to find which is better at helping the surgeon remove only the sick part while saving healthy tissue.
This trial studies a dye-based technique (using indocyanine green) to help surgeons identify lung segments during a lung cancer operation (segmentectomy). The goal is to improve how accurately and safely surgeons remove the affected part of the lung.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.